NDC 80777-275

Moderna COVID-19 Vaccine

Cx-024414

Moderna COVID-19 Vaccine is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Moderna Us, Inc.. The primary component is Cx-024414.

Product ID80777-275_1a7ad7e4-1d42-46a2-9696-d52119871a9e
NDC80777-275
Product TypeVaccine
Proprietary NameModerna COVID-19 Vaccine
Generic NameCx-024414
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-01-03
Marketing CategoryUNAPPROVED DRUG OTHER /
Labeler NameModerna US, Inc.
Substance NameCX-024414
Active Ingredient Strength0 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 80777-275-99

10 VIAL in 1 CARTON (80777-275-99) > 2.5 mL in 1 VIAL (80777-275-05)
Marketing Start Date2022-01-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Moderna COVID-19 Vaccine" or generic name "Cx-024414"

NDCBrand NameGeneric Name
80777-273Moderna COVID-19 VaccineCX-024414
80777-275Moderna COVID-19 VaccineCX-024414
80777-277Moderna COVID-19 VaccineCX-024414
80777-279Moderna COVID-19 VaccineCX-024414

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.